Technology News and Research

RSS

Researchers manipulate life span of yeast by mutating chemical residues

Collaborations between Johns Hopkins and National Taiwan University researchers have successfully manipulated the life span of common, single-celled yeast organisms by figuring out how to remove and restore protein functions related to yeast aging.

22 Nov 2011

FDA clears Aptus EndoStapling System to treat AAA

Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX™ Aortic Securement System.

21 Nov 2011

Roche establishes strategic alliance with Cedars-Sinai Medical Center

Roche announced today the establishment of a strategic alliance with Cedars-Sinai Medical Center in Los Angeles for the center to operate as a Roche Molecular Center of Excellence (MCOE) for the next five years.

From Roche Sequencing and Life Science 21 Nov 2011

Phototron third quarter revenue increases 127%

Phototron Holdings, Inc., the designer, manufacturer and seller of the innovative PHOTOTRON Hydroponic Indoor Grow System, today announced the availability of its third quarter 2011 financial results for the period ending September 30, 2011.

21 Nov 2011

Safeguard board renews prior authorization of share repurchase program

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that its Board of Directors has renewed its prior authorization of a share repurchase program.

21 Nov 2011

Covidien to acquire BÂRRX Medical

Covidien, a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire BÂRRX Medical, Inc. BÂRRX is the leader in treatment of Barrett's esophagus syndrome using bipolar radiofrequency (RF) ablation devices.

21 Nov 2011

Medizone, SMTC enter partnership to manufacture AsepticSure disinfection system

Medizone International, a leading-edge research and development company that specializes in decontamination and sterilization systems and SMTC Corporation, a global electronics manufacturing services provider, today jointly announce a new partnership agreement to manufacture Medizone's AsepticSure disinfection system.

21 Nov 2011

Princeton acquires Tru-D SmartUVC Room Decontamination System to improve patient care

In early September, Princeton Community Hospital added the Tru-D SmartUVC™ Room Decontamination System to its arsenal of new technology that helps disinfect environmental surfaces in patient rooms and in operating room suites.

21 Nov 2011

Aetna, Banner Health Network enter accountable care collaboration

Aetna today announced an accountable care collaboration with Banner Health Network and the introduction of Aetna Whole Health, a new commercial health care product that provides members access to highly coordinated care from physicians and facilities in the Banner Health Network.

21 Nov 2011

Clinical value of OrSense NBM 200 non-invasive Hb monitor for maternal health to be presented at 4th COGI

OrSense Ltd., announced today that two oral presentations on the clinical value of its NBM 200 non-invasive hemoglobin (Hb) monitor for maternal health and anemia monitoring prior, during and post delivery of pregnant women will be presented at the 4th Asia Pacific Congress on Controversies in Obstetrics Gynecology and Infertility (COGI).

21 Nov 2011

Positive preliminary results from Alnylam's ALN-TTR01 Phase I clinical trial for TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive preliminary results from its Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).

21 Nov 2011

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).

21 Nov 2011

Selecta commences SEL-068 Phase 1 clinical trial for smoking cessation and relapse prevention

Selecta Biosciences, Inc., a biopharmaceutical company developing a new class of synthetic vaccines and immunotherapies, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacodynamic profile of SEL-068, a nicotine vaccine candidate for smoking cessation and relapse prevention.

21 Nov 2011

InferX third quarter gross profit increases 75% to $283,806

InferX Corporation, a market leader in next generation Predictive Analytics products and solutions for the defense, healthcare and intelligence communities, today announced financial results for the third quarter of fiscal year 2011, which ended September 30, 2011.

21 Nov 2011

Cancer Research UK initiates recruitment for Stratified Medicine Programme

Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.

21 Nov 2011

New blood pressure remote monitoring program for Stamford employees, families

Stamford Hospital has launched a new blood pressure remote monitoring program for its employees and their families in order to detect risk factors for heart disease while helping to improve their overall health.

21 Nov 2011

OTS to market and disribute RaySearch's RayStation in South Korea

...

21 Nov 2011

Yeast protein in vaccines for more efficient immune response

To enhance the efficiency of vaccines, researchers at the division of chemical technology, Luleå University of Technolgy (LTU) have in co-operation with Karolinska Institute and Recopharma AB developed a strategy with the aim of directing vaccine components to critical parts of the immune system so that a more efficient immune response can be generated. The researchers have used a special type of protein produced in yeast.

21 Nov 2011

Retina Implant scientific advisory board approves multi-center phase of second human clinical trial

Retina Implant AG, the leading developer of subretinal implants for retinitis pigmentosa patients, today announced that its scientific advisory board is in full support of beginning the multi-center phase of the Company's second human clinical trial. The trial, which began in Tuebingen, Germany in 2010, will be expanded across Europe in five new sites, including two additional locations in Germany, Oxford, London and Budapest.

21 Nov 2011

CTI receives U.S. Patent Allowance for GlycoPolymer technology

Cell Therapeutics, Inc. (CTI) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application directed to increasing the plasma half-life of therapeutic proteins and peptides by recombinantly conjugating them to a novel, non-immunogenic peptide repeat sequence.

21 Nov 2011